Back

HCW Biologics keeps Buy rating as shares close at $1.68

Verifying
  • Michael Okunewitch maintained a Buy rating on HCW Biologics.
  • HCW Biologics closed at $1.68, while the consensus price target was $8.00.
  • Hing C Wong bought 23,210 HCWB shares for $59,881.80 in July 2026.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
HCW Biologics keeps Buy rating as shares close at $1.68 - CoinPost Terminal